Epmedin C is primarily used in research settings for its bioactive properties, particularly in studies related to cancer and cellular signaling pathways. It has shown potential as an inhibitor of specific kinases involved in tumor growth, making it a valuable tool in oncology-related drug discovery. Its ability to modulate protein activity allows scientists to probe intracellular mechanisms and understand disease progression at the molecular level. Due to its natural origin and structural complexity, Epmedin C also serves as a lead compound for the development of synthetic analogs with improved stability and efficacy. Currently, its applications remain confined to laboratory and preclinical research, with no widespread therapeutic use in clinical medicine.